Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I
Mucopolysaccharidosis type I (MPSI) is a lysosomal storage disease caused by insufficient iduronidase (IDUA) activity. Here, the authors use an ex vivo genome editing approach to overexpress IDUA in human hematopoietic stem and progenitor cells and show it can phenotypically correct MSPI in mouse mo...
Guardado en:
Autores principales: | Natalia Gomez-Ospina, Samantha G. Scharenberg, Nathalie Mostrel, Rasmus O. Bak, Sruthi Mantri, Rolen M. Quadros, Channabasavaiah B. Gurumurthy, Ciaran Lee, Gang Bao, Carlos J. Suarez, Shaukat Khan, Kazuki Sawamoto, Shunji Tomatsu, Nitin Raj, Laura D. Attardi, Laure Aurelian, Matthew H. Porteus |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8f066f14a98c44ea90d2d9109e701772 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Activity of daily living in mucopolysaccharidosis IVA patients: Evaluation of therapeutic efficacy
por: Hui Chen, et al.
Publicado: (2021) -
Molecular Analysis of Vietnamese Patients with Mucopolysaccharidosis Type I
por: Ngoc Thi Bich Can, et al.
Publicado: (2021) -
Engineering monocyte/macrophage−specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing
por: Samantha G. Scharenberg, et al.
Publicado: (2020) -
Author Correction: Engineering monocyte/macrophage−specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing
por: Samantha G. Scharenberg, et al.
Publicado: (2020) -
Gene correction for SCID-X1 in long-term hematopoietic stem cells
por: Mara Pavel-Dinu, et al.
Publicado: (2019)